• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

American Diabetes Association

ADA 2026 conference
Research

Scientists begin boycott of American Diabetes Association

Following the removal of five scientists from its annual conference in June, members of the ADA are suspending participation with the organization.
Darren Incorvaia Sep 11, 2026 6:30am
antibody translucent antibody antibody model

iBio champions AI-fueled obesity pivot as 1st asset hits clinic

Jun 26, 2026 5:00am
Novo Nordisk

ADA: Novo CSO says ‘jury still out’ on CagriSema v. retatrutide

Jun 10, 2026 11:10am
New Orleans
Favicon Fierce Pharma

Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says

Jun 8, 2026 3:12pm
Dexcom Stelo sensor on upper arm

ADA: Dexcom CGM shows benefit in non-insulin diabetes patients

Jun 8, 2026 11:15am
Boehringer Ingelheim ADA2026 BI

ADA: Tolerability questions linger for Boehringer's obesity drug

Jun 8, 2026 4:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings